TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
CING

Cingulate Inc

Healthcare · Biotechnology

4.80$ -0.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CING
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +370.8% -4.0% -23.1% -6.3% +12.0% -17.2%
– – – – – – –
– -44.0% +65.1% +7.0% +72.2% -39.0% +3.5%
– -13.5% +516.2% -30.7% -14.6% -14.7% +63.9%
– -45.6% +231.3% -15.4% +30.0% -31.3% +27.4%
– – – – – – –
– – -38.8% +420.8% +346.0% -87.2% +833.8%
– – – – – – –
– – -69.3% +470.5% -100.0% -13,250.0% –
– – – – – – –
– – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?